MRPS30 and lung cancer: The results suggested that the heterozygote TA of rs16901963 in MRPS30-DT was significantly associated with a reduced risk of lung cancer (OR = 0.67, 95% CI: 0.50–0.89, p = 0.006) in contrast with wide genotype AA.